glp 1 for gut health GLP-1 Support 2x Action Probiotic GLP-1 and Microbiome Repair for

The accumulated evidence over recent decades regarding the efficacy of new pharmacological treatments for obesity has positioned the glucagon-like peptide-1 (GLP-1) analogue as a key componentwhether as monoagonists, unimolecular multiagonists, or in combination therapies targeting multiple receptors.1 These drugs have made it possible to achieve previously unthinkable goals in terms of weight reduction and control of various obesity-related comorbidities (Fig

Glucagon-like peptide-1 analogues inhibit proliferation and increase apoptosis of human prostate cancer cells in vitro

The third patient lost 33% of body weight with only 8.7% of that loss attributable to LST well under the 25% benchmark

Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus